TRADING UPDATES: Unilever targets early December Ice Cream spin-off
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 0.235p on 17-11-2025 at 10:10:12 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.24p |
| Sell | 0.23p |
| Last Trade: | Sell 10,417.00 at 0.2305p |
| Day's Volume: | 3,625,621 |
| Last Close: | 0.235p |
| Open: | 0.235p |
| ISIN: | GB00BLH13C52 |
| Day's Range | 0.235p - 0.235p |
| 52wk Range: | 0.225p - 1.85p |
| Market Capitalisation: | £1.14m |
| VWAP: | 0.234987p |
| Shares in Issue: | 486.65m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
ValiRx (VAL) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 10,417 | 0.2305p | Ordinary |
09:57:04 - 17-Nov-25 |
| Buy* | 270 | 0.24p | Ordinary |
08:42:13 - 17-Nov-25 |
| Unknown* | 3,614,893 | 0.235p | Ordinary |
08:35:53 - 17-Nov-25 |
| Buy* | 41 | 0.24p | Ordinary |
08:35:14 - 17-Nov-25 |
| Buy* | 18,100 | 0.235p | Ordinary |
13:54:21 - 14-Nov-25 |
| Buy* | 4,255 | 0.235p | Ordinary |
12:41:30 - 14-Nov-25 |
| Buy* | 20,212 | 0.235p | Ordinary |
12:39:49 - 14-Nov-25 |
| Sell* | 173,161 | 0.231p | Ordinary |
12:31:46 - 14-Nov-25 |
| Sell* | 100,000 | 0.2305p | Ordinary |
11:21:13 - 14-Nov-25 |
| Buy* | 15,500 | 0.2364p | Ordinary |
16:25:27 - 13-Nov-25 |
ValiRx (VAL) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Nov 2025 2:16 pm | RNS | Holding(s) in Company |
| 10th Nov 2025 7:00 am | RNS | Holding(s) in Company |
| 4th Nov 2025 5:15 pm | RNS | Posting of Circular and Notice of General Meeting |
| 4th Nov 2025 7:00 am | RNS | Result of WRAP Retail Offer |
| 30th Oct 2025 7:21 am | RNS | WRAP Retail Offer for up to £300,000 |
| 30th Oct 2025 7:17 am | RNS | Fundraising of up to £1,050,000 |
| 14th Oct 2025 7:00 am | RNS | Inaphaea Commercial update |
| 29th Sep 2025 7:00 am | RNS | Half-year Report |
| 18th Sep 2025 7:00 am | RNS | Inaphaea Commercial Update |
| 1st Sep 2025 7:00 am | RNS | Cytolytix Commercial update |